Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VVN-461 by Viva Vision Biotech for Ocular Inflammation: Likelihood of Approval
VVN-461 is under clinical development by Viva Vision Biotech and currently in Phase II for Ocular Inflammation. According to GlobalData,...